Simply Wall St.
Thermo Fisher Datavant Deal Deepens Real World Data Role In Trials
📈
AI Sentiment
Highly Positive
8/10
- Home
- TMO
as of 02-26-2026 9:36am EST
$515.64
+$1.96
+0.38%
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
| Founded: | 1956 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 191.5B | IPO Year: | 1996 |
| Target Price: | $639.83 | AVG Volume (30 days): | 2.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 19 |
| Dividend Yield: | Dividend Payout Frequency: | quarterly | |
| EPS: | 12.53 | EPS Growth: | 6.99 |
| 52 Week Low/High: | $385.46 - $643.99 | Next Earning Date: | 04-30-2026 |
| Revenue: | $20,918,000,000 | Revenue Growth: | 14.47% |
| Revenue Growth (this year): | 6.17% | Revenue Growth (next year): | 5.21% |
| P/E Ratio: | 41.00 | Index: | |
| Free Cash Flow: | 7.3B | FCF Growth: | -13.40% |
Stock Insider Trading Activity of Thermo Fisher Scientific Inc (TMO)
Pettiti Gianluca
Sell
Executive Vice President
TMO Feb 9, 2026
Avg Cost/Share
$541.20
Shares
400
Total Value
$216,480.00
Owned After
20,752.223
SEC Form 4
Lagarde Michel
Sell
Executive Vice President & COO
TMO Dec 3, 2025
Avg Cost/Share
$583.72
Shares
32,000
Total Value
$18,668,526.38
Owned After
68,000.909
Lowery Frederick M.
Sell
Executive Vice President
TMO Dec 2, 2025
Avg Cost/Share
$581.94
Shares
6,912
Total Value
$4,022,369.28
Owned After
14,367.372
SEC Form 4
Lagarde Michel
Sell
Executive Vice President & COO
TMO Dec 2, 2025
Avg Cost/Share
$581.92
Shares
30,000
Total Value
$17,457,600.00
Owned After
68,000.909
SEC Form 4
Lowery Frederick M.
Sell
Executive Vice President
TMO Dec 1, 2025
Avg Cost/Share
$597.68
Shares
6,913
Total Value
$4,131,761.84
Owned After
14,367.372
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Pettiti Gianluca | TMO | Executive Vice President | Feb 9, 2026 | Sell | $541.20 | 400 | $216,480.00 | 20,752.223 | |
| Lagarde Michel | TMO | Executive Vice President & COO | Dec 3, 2025 | Sell | $583.72 | 32,000 | $18,668,526.38 | 68,000.909 | |
| Lowery Frederick M. | TMO | Executive Vice President | Dec 2, 2025 | Sell | $581.94 | 6,912 | $4,022,369.28 | 14,367.372 | |
| Lagarde Michel | TMO | Executive Vice President & COO | Dec 2, 2025 | Sell | $581.92 | 30,000 | $17,457,600.00 | 68,000.909 | |
| Lowery Frederick M. | TMO | Executive Vice President | Dec 1, 2025 | Sell | $597.68 | 6,913 | $4,131,761.84 | 14,367.372 |
Latest Thermo Fisher Scientific Inc News
TMO Breaking Stock News: Dive into TMO Ticker-Specific Updates for Smart Investing
GlobeNewswire
Preimplantation Genetic Testing Market Research and Global Forecast Report 2025-2030
📈
AI Sentiment
Highly Positive
9/10
Insider Monkey
Thermo Fisher Scientific Inc. (TMO) Carries a Mid-Single Digit Organic Growth Forecast
📊
AI Sentiment
Positive
7/10
GlobeNewswire
Cancer Diagnostics Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033
📈
AI Sentiment
Highly Positive
9/10
GlobeNewswire
Lung Cancer Diagnostics Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
Thermo Fisher’s Datavant Data Tie-Up Could Be A Game Changer For Thermo Fisher Scientific (TMO)
📊
AI Sentiment
Positive
7/10
Business Wire
Thermo Fisher Scientific to Present at Raymond James Annual Institutional Investors Conference
📈
AI Sentiment
Highly Positive
8/10
Compare TMO vs Leading Stocks
See how TMO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "TMO Thermo Fisher Scientific Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.